title: Percutaneous valve procedures: what is the future?
abstract: OBJECTIVE
  Since its introduction 27 years ago by Andreas Gruntzig, interventional cardiology has expanded its scope from coronary disease to peripheral, congenital, and also valve diseases.Percutaneous mitral commissurotomy and aortic valvuloplasty have been performed since the mid 1980s. Balloon commissurotomy has been used in tens of thousands of patients worldwide and provides good short- and long-term results in a wide range of patients. It has virtually replaced surgical commissurotomy in the management of mitral stenosis. On the other hand, percutaneous aortic valvuloplasty is almost abandoned worldwide due to its lack of efficacy and the risks involved.
  
  
  RESULTS
  The new techniques of percutaneous valve intervention are aortic valve replacement, and mitral valve repair. Both are at an early stage since the first in-man applications only started in 2002. Preliminary series show that these techniques are feasible; however, they must be further evaluated in comparison with contemporary treatment to accurately assess efficacy and risks. Today potential applications concern high-risk patients, however, after thorough evaluation this may be extended to others in the future.
  
  
  CONCLUSIONS
  Therefore, percutaneous interventions already play an important role in management of valvular heart disease, which is likely to grow in the future.
authors.affiliation: Bichat Hospital, Paris, France, Pitie-Salepetriere Hospital, Paris, France. cardio.sec1@bch.ap-hop-paris.fr
authors.forename: Alec
authors.initials: A
authors.lastname: Vahanian
authors.forename: Christophe
authors.initials: C
authors.lastname: Acar
mesh_terms: D001021:Aortic Valve / Q000473:pathology; D001024:Aortic Valve Stenosis / Q000628:therapy*; D002404:Catheterization / Q000379:methods* / Q000639:trends; D006801:Humans; D008943:Mitral Valve / Q000473:pathology; D008946:Mitral Valve Stenosis / Q000628:therapy*; D015607:Stents